| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Veradigm Inc. | Director | Common Stock | 56.6K | $243K | $4.30 | Jun 2, 2025 | Direct |
| Insight Molecular Diagnostics Inc. | Director | Common Stock, no par value | 36.6K | $113K | $3.10 | Jul 1, 2025 | Direct |
| STAAR SURGICAL CO | Director | Common Stock | 475 | $8.37K | $17.63 | Apr 24, 2025 | Direct |
| Oncocyte Corp | Director | Option to Purchase Common Stock | 30K | Jul 1, 2024 | Direct | ||
| STAAR SURGICAL CO | Director | Restricted Stock Units | 10.7K | Jun 18, 2025 | Direct | ||
| STAAR SURGICAL CO | Director | Common Stock Options | 2.44K | May 12, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | Jul 1, 2025 | 1 | $0 | 4 | Jul 3, 2025 | Director |
| STAA | STAAR SURGICAL CO | Jun 18, 2025 | 1 | $0 | 4 | Jun 20, 2025 | Director |
| MDRX | Veradigm Inc. | Jun 2, 2025 | 1 | $200K | 4 | Jun 3, 2025 | Director |
| STAA | STAAR SURGICAL CO | May 12, 2025 | 1 | $0 | 4 | May 13, 2025 | Director |
| STAA | STAAR SURGICAL CO | Apr 24, 2025 | 0 | $0 | 3 | Apr 29, 2025 | Director |
| MDRX | Veradigm Inc. | Mar 24, 2025 | 1 | $0 | 4 | Mar 26, 2025 | Director |
| MDRX | Veradigm Inc. | Feb 20, 2025 | 0 | $0 | 3 | Feb 26, 2025 | Director |
| OCX | Oncocyte Corp | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
| OCX | Oncocyte Corp | Jun 23, 2023 | 2 | $0 | 4 | Jun 27, 2023 | Director |
| OCX | Oncocyte Corp | Nov 30, 2022 | 0 | $0 | 3 | Dec 9, 2022 | Director |
| STAA | STAAR SURGICAL CO | Aug 10, 2021 | 9 | -$4.08M | 4 | Aug 12, 2021 | Director |
| STAA | STAAR SURGICAL CO | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |